Abstract
Controversial data were reported on GH response to different provocative stimuli in obese patients with polycystic ovary syndrome (PCOS). The objective of our study was to assess the effect of short-term fasting on GH response to combined stimulus with GHRH+GH-releasing peptide-6 (GHRP-6) in obese patients with PCOS and possible relation with leptin and insulin changes during fasting. Twelve obese PCOS women and nine obese control women participated in 3-day fasting. GH response, IGF-I, insulin and leptin were measured after GHRH+ GHRP-6, before and after short-term fasting. Obese PCOS patients had significantly greater GH peak after GHRH+GHRP-6 before fasting. Enhanced response to GH stimulation was found after fasting without substantial differences between obese PCOS and obese controls. Insulin and leptin significantly decreased, while insulin sensitivity significantly improved in both groups during fasting. In conclusion, obese PCOS patients have peculiar type of GH response to GHRH+GHRP-6 before fasting, possibly due to enhanced sensitivity of somatotrophs. Observed changes in insulin and leptin may participate in modulation of enhanced GH response after short-term fasting to GHRH+GHRP-6 in PCOS and obese controls.
Similar content being viewed by others
References
Morales A.J. Role of growth hormone in polycystic ovarian syndrome. Semin. Reprod. Endocrinol. 1977, 15: 177–182.
Franks S. Growth hormone and ovarian function. Bailliere’s Clin. Endocrinol. Metab. 1998, 12: 331–340.
Kaltsas T., Pontikides N., Krassas G.E., Seferiadis K., Lolis D., Messinis I.E. Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome. Hum. Reprod. 1999, 14: 2704–2708.
Maccario M., Tassone F., Grottoli S., Rossetto R., Gauna C., Ghigo E. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann. Endocrinol. 2002, 63: 140–144.
Villa P., Soranna L., Mancini A., et al. Effect of feeding on growth hormone response to growth hormone-releasing hormone in polycystic ovarian syndrome: relation with body weight and hyperinsulinism. Hum. Reprod. 2001, 16: 430–434.
Micić D., Kendereski A., Popović V., et al. Growth hormone response to GHRH, GHRP-6 and GHRH+GHRP-6 in patients with polycystic ovary syndrome. Clin. Endocrinol. 1996, 45: 385–390.
Penalva A., Gaztambide S., Vazquez J.A., Dieguez C., Casanueva F.F. Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal men. Clin. Endocrinol. 1990, 33: 171–176.
Melmed S. Insulin suppresses growth hormone secretion by rat pituitary cells. J. Clin. Invest. 1984, 73: 1425–1433.
Low L.C.K. Growth hormone-releasing hormone: clinical studies and therapeutic aspects. Neuroendocrinology 1991, 53: 37–40.
Ho K.Y., Veldhuis J.D., Johnson M.L., et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J. Clin. Invest. 1988, 81: 968–975.
Rasmussen M.H., Juul A., Kjems L.L., Skakkebaek N.E., Hilsted J. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J. Clin. Endocrinol. Metab. 1995, 80: 796–801.
Casanueva F.F., Dieguez C. Growth hormone secretato-gogues, physiological role and clinical utility. Trends Endocrinol. Metab. 1999, 10: 30–38.
Adams J., Polson D.W., Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 1986, 293: 355–359.
Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment insulin resistance and beta-cell function from fasting glucose and insulin concentration in man. Diabetologia 1985, 28: 412–419.
Piaditis G.P., Kounadi T.G., Rangou D.B., et al. Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome. Clin Endocrinol. 1995, 42: 635–640.
Lanzone A., Villa P., Fulhesu A.M., Pavone V., Caruso A., Mancuso S. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relatioship with obesity and hyperinsulinaemia. Hum. Reprod. 1995, 10: 1653–1657.
Prelević G.M., Wurzburger M.I., Balint-Perić L., Ginsburg J. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-1 concentrations in women with polycystic ovaries. Horm. Metab. Res. 1992, 37: 125–131.
Garcia-Rudaz M.C., Ropelato M.G., Escobar M.E., Veldhuis J.D., Barontini M. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome. Eur. J. Endocrinol. 2002, 147: 207–216.
Scachi M., Pincelli A.I., Cavagnini F. Growth hormone in obesity. Int. J. Obes. Relat. Metab. Disord. 1999; 23: 260–271.
Cordido F., Penalva A., Dieguez C., Casanueva F.F. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marker somatotroph secretory capability in obesity. J. Clin. Endocrinol. Metab. 1993, 76: 819–823.
Popović V., Pekić S., Simić M., et al. Physical activity or food intake prior to testing did not affect the reproducibility of GH secretion elicited by GH releasing hormone plus GH-releasing hexapeptide in normal adult subjects. Clin. Endocrinol. 2002, 56: 89–94.
Carlson H.E., Drenick E.J., Chopra I.J., Hershman J.M. Alterations in basal and TRH-stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men. J. Clin. Endocrinol. Metab. 1977, 45: 707–713.
Procopio M., Maccario M., Grottoli S., et al. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Clin. Endocrinol. 1995, 43: 665–669.
Megia A., Herranz L., Luna R., Gomez-Candela C., Pallardo F., Gonzalez-Gancedo P. Protein intake during aggressive calorie restriction in obesity determines growth hormone response to growth hormone-releasing hormone after weight loss. Clin. Endocrinol. 1993, 39: 217–220.
Muller A.F., Janssen J.A., Lamberts S.W., et al. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion. Clin. Endocrinol. 2001, 55: 461–467.
Penalva A., Pombo M., Carballow A., Barreiro J, Casanueva F.F., Dieguez C. Influence of sex, age, and adrenergic pathways on the growth hormone response to GHRP-6. Clin. Endocrinol. 1993, 38: 87–91.
Leal A., Lage M., Popović V., et al. A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test. Clin. Endocrinol. 2002, 57: 377–384.
Carro E., Senaris R.M., Seoane L.M., et al. Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion. Neuroendocrinology 1999, 69: 3–10.
Cocchi D., De Gennaro Colonna V., Bagnasco M., Bonacci D., Muller E.E. Leptin regulates GH secretion in the rat by acting on GHRH and somatostatinergic functions. J. Endocrinol. 1999, 162: 95–99.
Carro E., Seoane L.M., Senaris R., Casanueva F.F., Dieguez C. Leptin increases in vivo GH responses to GHRH and GH-releasing peptide-6 in food-deprived rats. Eur. J. Endocrinol. 2000; 142: 66–70.
Mizuno I., Okimura Y., Takahashi Y., Kaji H., Abe H., Chihara K. Leptin stimulates basal and GHRH-induced GH release from cultured rat anterior pituitary cell in vitro. Kobe J. Med. Sci. 1999, 45: 221–227.
Micić D., Macut Dj., Popović V., et al. Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome. Gynecol. Endocrinol. 1997, 11: 315–320.
Wu X., Sallinen K., Zhou S., Su Y., Pollanen P., Erkkola R. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome. Fertil. Steril. 2000, 73: 730–734.
Mauras N. Growth hormone and sex steroids. Interactions in puberty. Endocrinol. Metab. Clin. North. Am. 2001, 30: 529–544.
Ruiz E., Osorio A., Torres J.M., Ortega E. Evidence of different actions of testosterone, estradiol, FSH, and LH on the growth axis. Endocr. Res. 2001, 27: 25–33.
Fisker S., Norrelund H., Juul A., Skakkebaek N.E., Christiansen J.S., Jorgensen J.O. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males. Growth Horm. IGF Res. 2001, 11: 104–109.
Ciampelli M., Muzj G., Lenoni F., et al. Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2001, 86: 5324–5329.
McMahon C.D., Chapin L.T., Radcliff R.P., Lookingland K.J., Tucker H.A. GH- releasing peptide-6 overcomes refractoriness of somatotropes to GHRH after feeding. J. Endocrinol. 2001, 170: 235–241.
Muller A.F., Lamberts S.W., Janssen J.A., et al. Ghrelin drives GH secretion during fasting in man. Eur. J. Endocrinol. 2002, 146: 203–207.
Kasa-Vubu J.Z., Barkan A., Olton P., Meckmongkol T., Carlson N.E., Foster C.M. Incomplet modified fast in obese early pubertal girls leads to an increase in 24-hour growth hormone concentration and a lessening of the circadian pattern in leptin. J. Clin. Endocrinol. Metab. 2002, 87: 1885–1893.
Fernandez-Real J.M., Granada M.L., Ruzafa A., Casamitjana R. Ricart W. Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin. Clin. Endocrinol. 2000, 52: 159–164.
Kristensen K., Pedersen S.B., Fisker S., et al. Serum leptin levels and leptin expression in growth hormone (GH)-de-ficient and healthy adults: influence of GH treatment, gender, and fasting. Metabolism 1998, 47: 1514–1519.
Bergendahl M., Evans W.S., Pastor C., Patel A., Iranmanesh A., Veldhuis J.D. Short-term fasting suppresses leptin and (conversely) activates disorderly growth hormone secretion in midluteal phase women — a clinical research center study. J. Clin. Endocrinol. Metab. 1999, 84: 883–943.
Bergendahl M., Iranmanesch A., Evans W.S., Veldhuis J.D. Short-term fasting selectively supresses leptin pulse mass and 24-hour rhythmic leptin release in healthy midluteal phase women without disturbing leptin pulse frequency or its entropy control (pattern orderliness). J. Clin. Endocrinol. Metab. 2000, 85: 207–213.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Micić*, D., Šumarac-Dumanović, M., Macut, D. et al. Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting. J Endocrinol Invest 26, 333–340 (2003). https://doi.org/10.1007/BF03345181
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345181